已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

医学 生殖细胞肿瘤 生殖细胞 肿瘤科 卵巢癌 癌症研究 癌症 内科学 妇科 化疗 生物 基因 遗传学
作者
Xinyue Zhang,Jie Yang,Yang Xiang,Ming Wu,Dongyan Cao,Jinhui Wang,Jiaxin Yang
出处
期刊:International Journal of Gynecological Cancer [BMJ]
卷期号:34 (11): 1745-1752 被引量:1
标识
DOI:10.1136/ijgc-2024-005489
摘要

Objectives The aim of our study was to evaluate the feasibility of the modified International Germ Cell Cancer Collaborative Group risk classification system in Chinese female patients with malignant ovarian germ cell tumors and to identify predictive factors to enhance the risk classification system. Methods In this retrospective cohort analysis, patients with malignant ovarian germ cell tumors who received surgery with/without chemotherapy were included. These patients had been followed-up by Peking Union Medical College Hospital between 2011 to 2020. Patients without complete medical records or no follow-up information were excluded. Results The study enrolled a total of 271 patients. The risk model classified 106 (39.1%) patients as good-, 84 (31%) as intermediate-, and 81 (29.9%) as poor-risk. With a median follow-up time of 34 months (range 2–147), 48 (17.7%) recurrence and 16 (5.9%) deaths were observed. The risk classification significantly correlated with 3 year disease-free survival and overall survival (log rank p<0.001 and p=0.003, respectively). The survival outcomes of disease-free survival and overall survival were not statistically different among risk groups in patients who received neoadjuvant chemotherapy (log rank p=0.77 and 0.41, respectively). Univariate and multivariable analysis showed that tumor stage (p=0.033, hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.06 to 3.96) was significantly associated with relapse or progression of disease. Patients over age 40 years exhibited a poor prognosis. Conclusion The modified International Germ Cell Cancer Collaborative Group risk classification system was efficacious in patients with malignant ovarian germ cell tumors and was significantly associated with disease-free survival and overall survival. Risk assessment after neoadjuvant chemotherapy may be more predictive than stratification at initial diagnosis. Age and tumor stage were definitive prognostic factors for germ cell tumors, which may need to be incorporated in the stratification system.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
云帆发布了新的文献求助10
刚刚
1秒前
1秒前
1秒前
孤独的以菱完成签到 ,获得积分10
4秒前
一只快乐的小比熊完成签到 ,获得积分10
4秒前
111发布了新的文献求助10
4秒前
4114发布了新的文献求助10
7秒前
wx发布了新的文献求助10
7秒前
8秒前
叮当完成签到,获得积分10
9秒前
huangfan完成签到,获得积分20
10秒前
Laraineww完成签到 ,获得积分10
11秒前
风清扬发布了新的文献求助10
11秒前
ILS发布了新的文献求助30
12秒前
科研通AI2S应助科研通管家采纳,获得10
12秒前
大模型应助科研通管家采纳,获得10
12秒前
科目三应助科研通管家采纳,获得10
12秒前
完美世界应助科研通管家采纳,获得10
12秒前
情怀应助科研通管家采纳,获得10
12秒前
FashionBoy应助科研通管家采纳,获得10
12秒前
CodeCraft应助科研通管家采纳,获得10
13秒前
LPPQBB应助科研通管家采纳,获得50
13秒前
科研通AI6应助科研通管家采纳,获得10
13秒前
13秒前
科研通AI6应助科研通管家采纳,获得10
13秒前
LPPQBB应助科研通管家采纳,获得50
13秒前
科目三应助科研通管家采纳,获得10
13秒前
CipherSage应助科研通管家采纳,获得30
13秒前
共享精神应助科研通管家采纳,获得10
13秒前
13秒前
14秒前
BUlKY完成签到 ,获得积分10
14秒前
隐形大米完成签到 ,获得积分10
16秒前
Jonathan发布了新的文献求助10
18秒前
19秒前
21秒前
21秒前
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Bandwidth Choice for Bias Estimators in Dynamic Nonlinear Panel Models 2000
HIGH DYNAMIC RANGE CMOS IMAGE SENSORS FOR LOW LIGHT APPLICATIONS 1500
Constitutional and Administrative Law 1000
The Social Work Ethics Casebook: Cases and Commentary (revised 2nd ed.). Frederic G. Reamer 800
Vertébrés continentaux du Crétacé supérieur de Provence (Sud-Est de la France) 600
Vertebrate Palaeontology, 5th Edition 530
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5355997
求助须知:如何正确求助?哪些是违规求助? 4487796
关于积分的说明 13971120
捐赠科研通 4388602
什么是DOI,文献DOI怎么找? 2411155
邀请新用户注册赠送积分活动 1403696
关于科研通互助平台的介绍 1377356